Surajit Dey
Overview
Explore the profile of Surajit Dey including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
480
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Dey S, Lu W, Weber H, Young S, Larby J, Chia C, et al.
Am J Physiol Lung Cell Mol Physiol
. 2022 Aug;
323(4):L473-L483.
PMID: 35997281
Management of patients with asthma COPD overlap (ACO) is clinically challenging due to insufficient evidence of pathological changes in these patients. In this cross-sectional study, we evaluated airway remodeling in...
22.
Park S, DiVall M, Lee K, Lebovitz L, Dey S, Attarabeen O
Am J Pharm Educ
. 2022 Apr;
87(2):ajpe9012.
PMID: 35470173
Faculty workload is difficult to delineate and quantify equitably because of the various factors and diverse roles that define faculty positions. This is especially true in health professions education, including...
23.
Gaikwad A, Lu W, Dey S, Bhattarai P, Chia C, Larby J, et al.
ERJ Open Res
. 2022 Mar;
8(1).
PMID: 35350273
Background: Idiopathic pulmonary fibrosis (IPF) is a progressive, irreversible fibrotic interstitial lung disease. We performed size-based quantitation of pulmonary arterial remodelling in IPF and examined the role of endothelial-to-mesenchymal transition...
24.
Dey S, Eapen M, Chia C, Gaikwad A, Wark P, Sohal S
Am J Physiol Lung Cell Mol Physiol
. 2021 Oct;
322(1):L64-L83.
PMID: 34668439
Both asthma and COPD are heterogeneous diseases identified by characteristic symptoms and functional abnormalities, with airway obstruction common in both diseases. Asthma COPD overlap (ACO) does not define a single...
25.
Sarin E, Bisht N, Mohanty J, Joshi N, Kumar A, Dey S, et al.
Int J Health Plann Manage
. 2021 Aug;
36(6):2248-2262.
PMID: 34350636
District functionaries have ostensibly a major responsibility to develop evidence based plans. However, this responsibility is not commensurate with skills and expertise among functionaries in many Indian states. Vriddhi project-technical...
26.
Chand P, Kumar H, Badduri N, Gupta N, Bettada V, Madhunapantula S, et al.
Colloids Surf B Biointerfaces
. 2020 Dec;
199:111535.
PMID: 33360926
Cabazitaxel (CBZ) is a taxane derivative and an anti-microtubule agent effective against numerous cancers including drug-resistant cancers. In this study, CBZ loaded nanostructured lipid carriers (NLCs) were prepared by using...
27.
Kesharwani S, Mallya P, Kumar V, Jain V, Sharma S, Dey S
AAPS PharmSciTech
. 2020 Aug;
21(6):226.
PMID: 32761293
Approximately 40% of compounds in clinical drug development suffer from solubility and bioavailability challenges. Evidence from literature demonstrates the growing interest to utilize flavonoids as potential compounds owing to their...
28.
Gaikwad A, Eapen M, McAlinden K, Chia C, Larby J, Myers S, et al.
Expert Rev Respir Med
. 2020 Jul;
14(10):1027-1043.
PMID: 32659128
Introduction: Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, and irreversible fibrotic disease associated with respiratory failure. The disease remains idiopathic, but repeated alveolar epithelium injury, disruption of alveolar-capillary integrity,...
29.
Jain V, Kumar H, Anod H, Chand P, Gupta N, Dey S, et al.
J Control Release
. 2020 Jul;
326:628-647.
PMID: 32653502
Breast cancer (BC) is one of the most prevalent cancers in women. Triple-negative breast cancer (TNBC) in which the three major receptors i.e. estrogen receptor (ER), progesterone receptor (PR) and...
30.
Alzhrani R, Alhadidi Q, Bachu R, Shah Z, Dey S, Boddu S
Curr Eye Res
. 2017 Sep;
42(12):1667-1673.
PMID: 28937825
Purpose: The current work intends to study the activity of tanshinone IIA on secretion of vascular endothelial growth factor (VEGF) and expression of hypoxia inducible factor 1α (HIF-1α) in human...